nsc 664704 has been researched along with Nerve Pain in 1 studies
kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yeo, M | 1 |
| Chen, Y | 1 |
| Jiang, C | 1 |
| Chen, G | 1 |
| Wang, K | 1 |
| Chandra, S | 1 |
| Bortsov, A | 1 |
| Lioudyno, M | 1 |
| Zeng, Q | 1 |
| Wang, P | 1 |
| Wang, Z | 1 |
| Busciglio, J | 1 |
| Ji, RR | 1 |
| Liedtke, W | 1 |
1 other study available for nsc 664704 and Nerve Pain
| Article | Year |
|---|---|
Repurposing cancer drugs identifies kenpaullone which ameliorates pathologic pain in preclinical models via normalization of inhibitory neurotransmission.
Topics: Action Potentials; Analgesics; Animals; Benzazepines; Cancer Pain; Catenins; Cells, Cultured; Delta | 2021 |